Sjögren syndrome

P Brito-Zerón, C Baldini, H Bootsma… - Nature reviews Disease …, 2016 - nature.com
… Cryoglobulins are immunoglobulins that precipitate at <37 C in vitro 105 . Nearly 10% of
patients with SjS present with circulating cryoglobulins, which are overwhelmingly mixed (that is…

Anti-Sm and anti-RNP antibodies

P Migliorini, C Baldini, V Rocchi, S Bombardieri - Autoimmunity, 2005 - Taylor & Francis
… Anti-RNP antibodies react with proteins (70 Kd, A, C) that are associated with U1 RNA and
form U1snRNP. Anti-Sm and anti-RNP antibodies are directed towards both discontinuous …

Early diagnosis of primary Sjögren's syndrome: EULAR-SS task force clinical recommendations

P Brito-Zerón, E Theander, C Baldini… - Expert review of …, 2016 - Taylor & Francis
… [Citation66] reported that SjS was the main underlying systemic disease found in 20 patients
with biopsy-proven cryoglobulinemic renal disease without hepatitis C virus (HCV) infection …

[PDF][PDF] 2016 American College of Rheumatology/European League Against Rheumatism classification criteria for primary Sjögren's syndrome: a consensus and data …

…, T Dörner, A Tzoufias, C Baldini… - Arthritis & …, 2017 - Wiley Online Library
Objective To develop and validate an international set of classification criteria for primary
Sjögren's syndrome (SS) using guidelines from the American College of Rheumatology (ACR) …

Mechanisms and therapeutic implications of hypermutation in gliomas

…, R Sharaf, D Pavlick, LA Albacker, N Younan, C Baldini… - Nature, 2020 - nature.com
c, Response to temozolomide and CCNU in the glioblastoma PDCL BT145 following
knockout of MSH2, MSH6, MLH1 or PMS2 by CRISPR–Cas9. Dose–response curves were …

[HTML][HTML] Eosinophilic granulomatosis with polyangiitis (Churg–Strauss)(EGPA) Consensus Task Force recommendations for evaluation and management

M Groh, C Pagnoux, C Baldini, E Bel, P Bottero… - European journal of …, 2015 - Elsevier
C Low Further research is very likely to have an important impact on our confidence in the
… Chiara Baldini: fees paid to the institution by GSK for being an investigator in a clinical trial …

Primary Sjögren's syndrome as a multi-organ disease: impact of the serological profile on the clinical presentation of the disease in a large cohort of Italian patients

C Baldini, P Pepe, L Quartuccio, R Priori… - …, 2014 - academic.oup.com
Objective. The aims of this study were to describe the clinical presentation of primary SS (pSS)
in a large cohort of patients by assessing the prevalence of the patient subgroups at high …

Sjögren's Syndrome Disease Damage Index and disease activity index: scoring systems for the assessment of disease damage and disease activity in Sjögren's …

C Vitali, G Palombi, C Baldini, M Benucci… - … : Official Journal of …, 2007 - Wiley Online Library
Objective. To develop valid instruments for the assessment of disease-related damage and
disease activity in Sjögren’s syndrome (SS). Methods. Data on 206 patients with primary SS …

Mepolizumab for eosinophilic granulomatosis with polyangiitis: a European multicenter observational study

…, P Novikov, C Baldini, C Lombardi… - Arthritis & …, 2022 - Wiley Online Library
Objective Mepolizumab proved to be an efficacious treatment for eosinophilic granulomatosis
with polyangiitis (EGPA) at a dose of 300 mg every 4 weeks in the randomized, controlled …

[HTML][HTML] Genome-wide association study of eosinophilic granulomatosis with polyangiitis reveals genomic loci stratified by ANCA status

…, J Liley, RMR Coulson, W Astle, C Baldini… - Nature …, 2019 - nature.com
… and regulatory regions in promoter capture Hi-C datasets using the CHiCP browser (see
the ‘Methods’ section). We emphasise that whilst Hi-C data can suggest a link between a …